GROWTH-HORMONE RESPONSE IN PARKINSON'S DISEASE
- 28 February 1976
- journal article
- other
- Published by Elsevier BV in The Lancet
- Vol. 307 (7957), 483-484
- https://doi.org/10.1016/s0140-6736(76)91505-1
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- GROWTH-HORMONE RESPONSE TO BROMOCRIPTINE IN PARKINSONISMThe Lancet, 1976
- STIMULANT PROPERTIES OF BROMOCRIPTINE ON CENTRAL DOPAMINE RECEPTORS IN COMPARISON TO APOMORPHINE, (+)‐AMPHETAMINE AND l‐DOPABritish Journal of Pharmacology, 1976
- BROMOCRIPTINE IN PARKINSONISMThe Lancet, 1975
- Effect of ergot drugs on central 5-hydroxytryptamine neurons: Evidence for 5-hydroxytryptamine release or 5-hydroxytryptamine receptor stimulationEuropean Journal of Pharmacology, 1975
- Apomorphine: Effect on Growth HormoneJournal of Clinical Endocrinology & Metabolism, 1975
- Dissociation of Growth Hormone and Prolactin Secretion in Parkinson's Disease Following Chronic l -Dopa TherapyJournal of Clinical Endocrinology & Metabolism, 1974
- Defective Release of Growth Hormone in Parkinsonism Improved by LevodopaNew England Journal of Medicine, 1973
- Growth Hormone Responses to L-Dopa in Depressed PatientsScience, 1972
- THE BRAIN-STEM LESIONS IN PARKINSONISMJournal of Neurology, Neurosurgery & Psychiatry, 1953